Physician

Robert Oliver Morton, MD

According to 2025 Medicare claims, Robert Morton, MD (NPI: 1336222504) practices psychiatry in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is ROBERT O. MORTON, M.D., PLLC (NPI: 1144870478; TIN: 830802852) and primary practice location at 74820-9415.

Morton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,644 traditional Medicare patients, billed 19,398 HCPCS/CPT codes, and received $1,054,006 in Medicare payments. The top billing code was 99239 (Hospital discharge day management, more than 30 minutes). Part D data shows 115,669 prescription claims across 2,187 beneficiaries totaling $35,237,337 in drug costs, led by Ingrezza (Valbenazine Tosylate). 2022 DME data shows 43 claims. Open Payments data shows 726 records totaling $411,514. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $8,119,010 to $35,237,337. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $235 and ending at $4,515.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,779	17,928	$899,839
2016	1,913	23,536	$1,268,995
2017	1,924	27,986	$1,454,161
2018	1,944	27,645	$1,504,259
2019	1,971	26,621	$1,500,380
2020	1,848	26,481	$1,448,405
2021	1,911	25,364	$1,520,453
2022	1,869	24,303	$1,406,523
2023	1,801	22,250	$1,345,202
2024	1,644	19,398	$1,054,006

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,706	64,556	$8,119,010
2016	1,784	67,601	$7,460,611
2017	1,755	73,162	$9,367,487
2018	1,852	78,142	$13,183,544
2019	2,024	84,492	$17,565,560
2020	1,966	87,933	$19,769,382
2021	1,976	92,337	$22,064,658
2022	2,042	99,974	$30,259,015
2023	2,081	105,265	$32,791,515
2024	2,187	115,669	$35,237,337

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	74	$10,414
2016	N/R	45	$5,913
2017	11	60	$383
2018	N/R	23	$215
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	26	$372
2022	N/R	43	$556
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99239	Hospital discharge day management, more than 30 minutes	314	384	$75
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	301	1,004	$75
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	346	7,997	$53
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,308	8,044	$51
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	299	359	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ingrezza	Valbenazine Tosylate	874	23,177	$6,361,435
Austedo Xr	Deutetrabenazine	642	17,668	$4,751,170
Vraylar	Cariprazine Hcl	2,852	65,069	$3,221,005
Austedo	Deutetrabenazine	360	8,450	$2,422,317
Nuplazid	Pimavanserin Tartrate	414	10,685	$1,893,175

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	726	$411,514	Teva Pharmaceuticals USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Oliver Morton, MD?

Tedicare shows public-source Medicare data for Robert Oliver Morton, MD (NPI 1336222504), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Oliver Morton, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Oliver Morton, MD?

Robert Oliver Morton, MD is linked to ROBERT O. MORTON, M.D., PLLC (billing NPI 1144870478) in the available physician profile data.

Does Robert Oliver Morton, MD have Open Payments data?

Robert Oliver Morton, MD has 726 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.